Westlake Biopartners Fund Ii, L.p. - Net Worth and Insider Trading

Westlake Biopartners Fund Ii, L.p. Net Worth

The estimated net worth of Westlake Biopartners Fund Ii, L.p. is at least $45 Million dollars as of 2024-05-08. Westlake Biopartners Fund Ii, L.p. is the 10% Owner of Acelyrin Inc and owns about 9,790,729 shares of Acelyrin Inc (SLRN) stock worth over $45 Million. Details can be seen in Westlake Biopartners Fund Ii, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Westlake Biopartners Fund Ii, L.p. has not made any transactions after 2023-05-09 and currently still holds the listed stock(s).

Transaction Summary of Westlake Biopartners Fund Ii, L.p.

To

Westlake Biopartners Fund Ii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Westlake Biopartners Fund Ii, L.p. owns 1 companies in total, including Acelyrin Inc (SLRN) .

Click here to see the complete history of Westlake Biopartners Fund Ii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Westlake Biopartners Fund Ii, L.p.

Ticker Comapny Transaction Date Type of Owner
SLRN Acelyrin Inc 2023-05-09 10 percent owner

Westlake Biopartners Fund Ii, L.p. Latest Holdings Summary

Westlake Biopartners Fund Ii, L.p. currently owns a total of 1 stock. Westlake Biopartners Fund Ii, L.p. owns 9,790,729 shares of Acelyrin Inc (SLRN) as of May 9, 2023, with a value of $45 Million.

Latest Holdings of Westlake Biopartners Fund Ii, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SLRN Acelyrin Inc 2023-05-09 9,790,729 4.62 45,184,214

Holding Weightings of Westlake Biopartners Fund Ii, L.p.


Westlake Biopartners Fund Ii, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Westlake Biopartners Fund Ii, L.p. has made a total of 1 transactions in Acelyrin Inc (SLRN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Acelyrin Inc is the acquisition of 1,250,000 shares on May 9, 2023, which cost Westlake Biopartners Fund Ii, L.p. around $23 Million.

Insider Trading History of Westlake Biopartners Fund Ii, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Westlake Biopartners Fund Ii, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Westlake Biopartners Fund Ii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Westlake Biopartners Fund Ii, L.p. is 3.28%. GuruFocus also compares Westlake Biopartners Fund Ii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Westlake Biopartners Fund Ii, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Westlake Biopartners Fund Ii, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Westlake Biopartners Fund Ii, L.p.

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -24.26
Relative Return to S&P 500(%) -28.62

Westlake Biopartners Fund Ii, L.p. Ownership Network

Ownership Network List of Westlake Biopartners Fund Ii, L.p.

No Data

Ownership Network Relation of Westlake Biopartners Fund Ii, L.p.


Westlake Biopartners Fund Ii, L.p. Owned Company Details

What does Acelyrin Inc do?

Who are the key executives at Acelyrin Inc?

Westlake Biopartners Fund Ii, L.p. is the 10 percent owner of Acelyrin Inc. Other key executives at Acelyrin Inc include director & Chief Executive Officer Shao-lee Lin , Interim CFO Gil M Labrucherie , and director & 10 percent owner Beth C Seidenberg .

Acelyrin Inc (SLRN) Insider Trades Summary

Over the past 18 months, Westlake Biopartners Fund Ii, L.p. made 1 insider transaction in Acelyrin Inc (SLRN) with a net purchase of 1,250,000. Other recent insider transactions involving Acelyrin Inc (SLRN) include a net sale of 36,353 shares made by Shao-lee Lin , a net purchase of 1,310,000 shares made by Beth C Seidenberg , and a net purchase of 50,000 shares made by Henry O Gosebruch .

In summary, during the past 3 months, insiders sold 25,662 shares of Acelyrin Inc (SLRN) in total and bought 0 shares, with a net sale of 25,662 shares. During the past 18 months, 36,353 shares of Acelyrin Inc (SLRN) were sold and 2,647,332 shares were bought by its insiders, resulting in a net purchase of 2,610,979 shares.

Acelyrin Inc (SLRN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acelyrin Inc Insider Transactions

No Available Data

Westlake Biopartners Fund Ii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Westlake Biopartners Fund Ii, L.p.. You might contact Westlake Biopartners Fund Ii, L.p. via mailing address: 3075 Townsgate Road, Suite 140, Westlake Village Ca 91361.

Discussions on Westlake Biopartners Fund Ii, L.p.

No discussions yet.